Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2003, No. 03
(2003; 14 pages) View the PDF document
Table of Contents
Open this folder and view contentsREGULATORY MATTERS
Open this folder and view contentsSAFETY OF MEDICINES
Open this folder and view contentsCURRENT CONCERNS
Open this folder and view contentsDRUGS OF INTEREST
Open this folder and view contentsFEATURE

WHO Pharmaceuticals Newsletter 2003, No. 03


In the previous newsletter we had appealed to the Member States for greater communication on drug safety and regulatory information. We are happy to record that Bangladesh and the Republic of Maldives have responded with some recent regulatory developments in their countries. We acknowledge the Regional Adviser’s pivotal role in facilitating this information exchange.

Counterfeit medicines continue to threaten the healthcare world. Cleverly designed fake holograms of product labels and imperceptible changes to the label text make counterfeiting ever more hard to detect. In this issue, we have included an article on fake artesunate tablets, to alert readers to the level of sophistication in the world of counterfeiting.

The feature section presents an article on the workshop on pharmacovigilance that was held in Zambia in March 2003. The workshop was the first of many initiatives being planned to integrate pharmacovigilance into public health programmes.


to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017